Appili Therapeutics Inc.
APLIF
$0.01
$0.00-1.27%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.36% | 4.80% | 20.49% | -668.41% | 142.42% |
| Total Depreciation and Amortization | -- | -100.00% | -7.69% | 18.18% | -24.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 71.67% | 363.56% | -158.63% | -82.20% | 7.45% |
| Change in Net Operating Assets | -26.57% | 22.37% | -69.22% | 651.39% | 76.50% |
| Cash from Operations | -4.58% | 63.60% | -11,884.78% | -100.64% | 328.04% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 533.33% | 98.01% | -2.73% | 34.74% | -62.68% |
| Issuance of Common Stock | -43.66% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 168.61% | 42.07% | -263.85% | 20.73% | -26.15% |
| Cash from Financing | -18.56% | 290.75% | -83.66% | 28.17% | -46.90% |
| Foreign Exchange rate Adjustments | 60.00% | -109.11% | 211.42% | -181.91% | 1,357.58% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -27.38% | 82.70% | -655.63% | -110.27% | 312.19% |